TLRY - Tilray Brands, Inc. Stock Analysis | Stock Taper
Logo

About Tilray Brands, Inc.

https://www.tilray.com

Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business.

Irwin David Simon

CEO

Irwin David Simon

Compensation Summary
(Year 2025)

Salary $1,988,000
Bonus $3,369,950
Stock Awards $4,729,400
All Other Compensation $208,262
Total Compensation $10,295,612
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Went public July 19, 2018
Method of going public IPO
Full time employees 2,650

Split Record

Date Type Ratio
2025-12-02 Reverse 1:10
2021-05-03 Reverse 8381:10000

ETFs Holding This Stock

Ratings Snapshot

Rating : C

Discounted Cash Flow 1
Return On Equity 1
Return On Assets 1
Debt To Equity 3
Price To Earnings 1
Price To Book 4
Overall Score 2

Most Recent Analyst Grades

Grade Summary

Buy 1
Neutral 2

Showing Top 3 of 3

Price Target

Target High $10
Target Low $2
Target Median $6
Target Consensus $6

Institutional Ownership